Literature DB >> 29693745

Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells.

Nawneet Mishra1, K Sony Reddy2, Uddhav Timilsina1, Deepak Gaur3, Ritu Gaur1.   

Abstract

Human APOBEC3B (A3B), like other APOBEC3 members, is a cytosine deaminase which causes hypermutation of single stranded genome. Recent studies have shown that A3B is predominantly elevated in multiple cancer tissues and cell lines such as the bladder, cervix, lung, head and neck, and breast. Upregulation and activation of A3B in developing tumors can cause an unexpected cluster of mutations which promote cancer development and progression. The cellular proteins which facilitate A3B function through direct or indirect interactions remain largely unknown. In this study, we performed LC-MS-based proteomics to identify cellular proteins which coimmunoprecipitated with A3B. Our results indicated a specific interaction of A3B with hnRNP A3 (heterogeneous nuclear ribonucleoprotein). This interaction was verified by co-immunoprecipitation and was found to be RNA-dependent. Furthermore, A3B and hnRNP A3 colocalized as evident from immunofluorescence analysis.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  APOBEC3B; cancer; heterogeneous nuclear ribonucleoprotein; proteomics

Mesh:

Substances:

Year:  2018        PMID: 29693745     DOI: 10.1002/jcb.26855

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B.

Authors:  Yanmeng Chen; Bocun Shen; Xiaochuan Zheng; Quanxin Long; Jie Xia; Yao Huang; Xuefei Cai; Deqiang Wang; Juan Chen; Ni Tang; Ailong Huang; Yuan Hu
Journal:  Emerg Microbes Infect       Date:  2020-02-14       Impact factor: 7.163

2.  Profiling of subcellular EGFR interactome reveals hnRNP A3 modulates nuclear EGFR localization.

Authors:  Tong-Hong Wang; Chih-Ching Wu; Kuo-Yen Huang; Wen-Yu Chuang; Chuen Hsueh; Hsin-Jung Li; Chi-Yuan Chen
Journal:  Oncogenesis       Date:  2020-04-22       Impact factor: 7.485

3.  APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression.

Authors:  Hiroyuki Yamazaki; Kotaro Shirakawa; Tadahiko Matsumoto; Yasuhiro Kazuma; Hiroyuki Matsui; Yoshihito Horisawa; Emani Stanford; Anamaria Daniela Sarca; Ryutaro Shirakawa; Keisuke Shindo; Akifumi Takaori-Kondo
Journal:  PLoS One       Date:  2020-01-08       Impact factor: 3.240

4.  Abnormal expression of HNRNPA3 in multistep hepatocarcinogenesis.

Authors:  Xinlu Ren; Yi Dong; Miao Duan; Hui Zhang; Peng Gao
Journal:  Oncol Lett       Date:  2020-11-17       Impact factor: 2.967

5.  Alterations of Asymmetric Dimethylarginine (ADMA)-Containing Protein Profiles Associated with Chronic Pancreatitis Pathogenesis.

Authors:  Chaochao Tan; Yan Xiao; Xiangping Huang; Ling Wu; Ying Huang
Journal:  J Inflamm Res       Date:  2021-12-24

6.  ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells.

Authors:  Yasuhiro Kazuma; Kotaro Shirakawa; Yusuke Tashiro; Hiroyuki Yamazaki; Ryosuke Nomura; Yoshihito Horisawa; Suguru Takeuchi; Emani Stanford; Yoshinobu Konishi; Hiroyuki Matsui; Tadahiko Matsumoto; Fumiko Tanabe; Ryo Morishita; Shinji Ito; Akifumi Takaori-Kondo
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

Review 7.  Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets.

Authors:  Ya Lu; Xinyue Wang; Quan Gu; Juan Wang; Ying Sui; Jianzhong Wu; Jifeng Feng
Journal:  Cell Death Discov       Date:  2022-07-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.